{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T08:53:01Z","timestamp":1790499181018,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","content-domain":{"domain":["sleep-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.sleep.2014.01.021","type":"journal-article","created":{"date-parts":[[2014,3,21]],"date-time":"2014-03-21T12:15:27Z","timestamp":1395404127000},"page":"681-687","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Effects of pitolisant, a histamine H3 inverse agonist, in drug-resistant idiopathic and symptomatic hypersomnia: a chart review"],"prefix":"10.1016","volume":"15","author":[{"given":"Smaranda","family":"Leu-Semenescu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandy","family":"Nittur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Golmard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Arnulf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sleep.2014.01.021_b0005","article-title":"The international classification of sleep disorders \u2013 revised","author":"American Academy of Sleep Medicine","year":"2005"},{"key":"10.1016\/j.sleep.2014.01.021_b0010","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1093\/sleep\/32.6.753","article-title":"Idiopathic hypersomnia with and without long sleep time: a controlled series of 75 patients","volume":"32","author":"Vernet","year":"2009","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2014.01.021_b0015","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2869.2010.00824.x","article-title":"Subjective symptoms in idiopathic hypersomnia: beyond excessive sleepiness","volume":"19","author":"Vernet","year":"2010","journal-title":"J Sleep Res"},{"key":"10.1016\/j.sleep.2014.01.021_b0020","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004685","article-title":"Modulation of vigilance in the primary hypersomnias by endogenous enhancement of GABAA receptors","volume":"4","author":"Rye","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.sleep.2014.01.021_b0025","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/sleep\/32.2.181","article-title":"CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome","volume":"32","author":"Kanbayashi","year":"2009","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2014.01.021_b0030","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1365-2869.2010.00819.x","article-title":"Cerebrospinal fluid histamine levels are decreased in patients with narcolepsy and excessive daytime sleepiness of other origin","volume":"19","author":"Bassetti","year":"2010","journal-title":"J Sleep Res"},{"key":"10.1016\/j.sleep.2014.01.021_b0035","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.5665\/sleep.2114","article-title":"Normal cerebrospinal fluid histamine and tele-methylhistamine levels in hypersomnia conditions","volume":"35","author":"Dauvilliers","year":"2012","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2014.01.021_b0040","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1093\/sleep\/30.12.1705","article-title":"Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin","volume":"30","author":"Morgenthaler","year":"2007","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2014.01.021_b0045","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.sleep.2011.03.010","article-title":"Benefit and risk of modafinil in idiopathic hypersomnia versus. narcolepsy with cataplexy","volume":"12","author":"Lavault","year":"2011","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2014.01.021_b0050","doi-asserted-by":"crossref","first-page":"562","DOI":"10.5664\/jcsm.27658","article-title":"Idiopathic hypersomnia: clinical features and response to treatment","volume":"5","author":"Ali","year":"2009","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.sleep.2014.01.021_b0055","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1093\/sleep\/30.10.1274","article-title":"Idiopathic hypersomnia: a study of 77 cases","volume":"30","author":"Anderson","year":"2007","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2014.01.021_b0060","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.sleep.2011.07.014","article-title":"Quality of life in patients with narcolepsy with cataplexy, narcolepsy without cataplexy, and idiopathic hypersomnia without long sleep time: comparison between patients on psychostimulants, drug-naive patients and the general Japanese population","volume":"13","author":"Ozaki","year":"2012","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2014.01.021_b0065","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.sleep.2012.07.008","article-title":"Mazindol in narcolepsy and idiopathic and symptomatic hypersomnia refractory to stimulants: a long-term chart review","volume":"14","author":"Nittur","year":"2013","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2014.01.021_b0070","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.nbd.2007.12.003","article-title":"An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin\u2013\/\u2013 mice and patients","volume":"30","author":"Lin","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.sleep.2014.01.021_b0075","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S1474-4422(13)70225-4","article-title":"Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial","volume":"12","author":"Dauvilliers","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.sleep.2014.01.021_b0080","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/WNF.0b013e318246879d","article-title":"Pitolisant, an inverse agonist of the histamine H3 receptor: an alternative stimulant for narcolepsy\u2013cataplexy in teenagers with refractory sleepiness","volume":"35","author":"Inocente","year":"2012","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.sleep.2014.01.021_b0085","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.sleep.2014.01.021_b0090","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1476-5381.2011.01286.x","article-title":"The histamine H3 receptor: from discovery to clinical trials with pitolisant","volume":"163","author":"Schwartz","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.sleep.2014.01.021_b0095","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.sleep.2013.04.010","article-title":"Alerting and psychomotor performance effects of the histamine H3 inverse agonist MK-0249 in obstructive sleep apnea patients on CPAP with excessive daytime sleepiness: a randomized adaptive crossover study","volume":"14","author":"Herring","year":"2013","journal-title":"Sleep Med"},{"issue":"Suppl 1","key":"10.1016\/j.sleep.2014.01.021_b0100","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1007\/s00011-006-0509-7","article-title":"Influence of (R)-alpha-methylhistamine on the histamine H3 receptor in the rat gastrointestinal tract","volume":"56","author":"Chazot","year":"2007","journal-title":"Inflamm Res"},{"key":"10.1016\/j.sleep.2014.01.021_b0105","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1136\/gut.2004.061762","article-title":"Selective expression of histamine receptors H1R, H2R, and H4R, but not H3R, in the human intestinal tract","volume":"55","author":"Sander","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.sleep.2014.01.021_b0110","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fnsys.2012.00051","article-title":"Histamine and motivation","volume":"6","author":"Torrealba","year":"2012","journal-title":"Front Syst Neurosci"},{"key":"10.1016\/j.sleep.2014.01.021_b0115","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00415-011-6171-1","article-title":"Increasing histamine neurotransmission in Gilles de la Tourette syndrome","volume":"259","author":"Hartmann","year":"2011","journal-title":"J Neurol"},{"key":"10.1016\/j.sleep.2014.01.021_b0120","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/bph.12149","article-title":"Preclinical evaluation of the abuse potential of pitolisant, a histamine H3 receptor inverse agonist\/antagonist compared with modafinil","volume":"169","author":"Uguen","year":"2013","journal-title":"Br J Pharmacol"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945714000951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945714000951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,16]],"date-time":"2020-08-16T12:50:59Z","timestamp":1597582259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945714000951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S1389945714000951"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2014.01.021","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of pitolisant, a histamine H3 inverse agonist, in drug-resistant idiopathic and symptomatic hypersomnia: a chart review","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2014.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}